Table 1.
Association of WTAP expression with clinicopathologic characteristics of the renal cancer patients
| Parameters | Number of cases | WTAP expression | P-value | |
|---|---|---|---|---|
| Low (%) | High (%) | |||
| Age (years) | 60 | 36(60) | 24(40) | 0.496 |
| < 60 | 25 | 13(52) | 12(48) | |
| ≥ 60 | ||||
| Gender | 0.244 | |||
| Male | 51 | 32(62.7) | 19(37.3) | |
| Female | 34 | 17(50) | 17(50) | |
| Tumor size (cm) | 0.015a | |||
| ≤ 4 | 39 | 28(71.8) | 11(28.2) | |
| > 4 | 46 | 21(45.7) | 25(54.3) | |
| Histological grade | 0.22 | |||
| I-II | 71 | 43(60.6) | 28(39.4) | |
| III-IV | 14 | 6(42.9) | 8(57.1) | |
| TNM stage | 0.002a | |||
| I | 62 | 42(67.7) | 20(32.3) | |
| II-IV | 23 | 7(30.4) | 16(69.6) | |
| CDK2 | 0.004a | |||
| Negative | 34 | 26(76.5) | 8(23.5) | |
| Positive | 51 | 23(45.1) | 28(54.9) | |
aStatistically significant